| US5514646A
              (en) | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain | 
        
          | US5424286A
              (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same | 
        
          | DE19616486C5
              (de) | 1996-04-25 | 2016-06-30 | Royalty Pharma Collection Trust | Verfahren zur Senkung des Blutglukosespiegels in Säugern | 
        
          | HU227021B1
              (en) | 1996-08-30 | 2010-05-28 | Novo Nordisk As | Glp-1 derivatives | 
        
          | DE69723869T2
              (de) | 1996-12-31 | 2004-04-22 | Dr. Reddy's Laboratories Ltd. | Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten | 
        
          | US6506559B1
              (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA | 
        
          | EP2583675A1
              (en) | 1998-02-02 | 2013-04-24 | Trustees Of Tufts College | Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism | 
        
          | AUPP249298A0
              (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I | 
        
          | US6566131B1
              (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of Smad6 expression | 
        
          | CN1308828A
              (zh) | 1998-06-30 | 2001-08-15 | 松下电器产业株式会社 | 网络控制系统及其方法 | 
        
          | US20030219427A1
              (en)
            
            * | 1998-08-18 | 2003-11-27 | Allen Hamish J. | TPL-2/COT kinase and methods of use | 
        
          | US6410323B1
              (en) | 1999-08-31 | 2002-06-25 | Isis Pharmaceuticals, Inc. | Antisense modulation of human Rho family gene expression | 
        
          | US6107091A
              (en) | 1998-12-03 | 2000-08-22 | Isis Pharmaceuticals Inc. | Antisense inhibition of G-alpha-16 expression | 
        
          | US5981732A
              (en) | 1998-12-04 | 1999-11-09 | Isis Pharmaceuticals Inc. | Antisense modulation of G-alpha-13 expression | 
        
          | ES2230912T3
              (es) | 1998-12-07 | 2005-05-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Analogo de glp-1. | 
        
          | US6046321A
              (en) | 1999-04-09 | 2000-04-04 | Isis Pharmaceuticals Inc. | Antisense modulation of G-alpha-i1 expression | 
        
          | EP1076066A1
              (en) | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels | 
        
          | GB9927444D0
              (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression | 
        
          | WO2001068836A2
              (en) | 2000-03-16 | 2001-09-20 | Genetica, Inc. | Methods and compositions for rna interference | 
        
          | US6365354B1
              (en) | 2000-07-31 | 2002-04-02 | Isis Pharmaceuticals, Inc. | Antisense modulation of lysophospholipase I expression | 
        
          | US6566135B1
              (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 6 expression | 
        
          | HUP0200849A2
              (hu) | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | 
        
          | HUP0202001A2
              (hu) | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok | 
        
          | WO2004037169A2
              (en) | 2002-10-18 | 2004-05-06 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | 
        
          | UY28103A1
              (es) | 2002-12-03 | 2004-06-30 | Boehringer Ingelheim Pharma | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos | 
        
          | DE10333935A1
              (de) | 2003-07-25 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | PE20050249A1
              (es) | 2003-07-25 | 2005-06-01 | Aventis Pharma Gmbh | Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos | 
        
          | BR122019021416A2
              (en:Method) | 2003-09-19 | 2019-12-21 |  |  | 
        
          | TW200519105A
              (en) | 2003-10-20 | 2005-06-16 | Lg Life Science Ltd | Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent | 
        
          | DE10359098A1
              (de) | 2003-12-17 | 2005-07-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel | 
        
          | WO2005110410A2
              (en) | 2004-05-14 | 2005-11-24 | Abbott Laboratories | Kinase inhibitors as therapeutic agents | 
        
          | DE102004037554A1
              (de) | 2004-08-03 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102004038270A1
              (de) | 2004-08-06 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102004038268A1
              (de) | 2004-08-06 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102004038269A1
              (de) | 2004-08-06 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102004039507A1
              (de) | 2004-08-14 | 2006-03-02 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | ATE481969T1
              (de) | 2004-10-01 | 2010-10-15 | Merck Sharp & Dohme | Aminopiperidine als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes | 
        
          | US8030273B2
              (en) | 2004-10-07 | 2011-10-04 | Novo Nordisk A/S | Protracted exendin-4 compounds | 
        
          | US7893017B2
              (en) | 2004-10-07 | 2011-02-22 | Novo Nordisk A/S | Protracted GLP-1 compounds | 
        
          | JP2006160733A
              (ja) | 2004-11-15 | 2006-06-22 | Taisho Pharmaceut Co Ltd | シアノフルオロピロリジン誘導体を有効成分として含有する医薬 | 
        
          | JP4999698B2
              (ja) | 2004-11-29 | 2012-08-15 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療または予防用のジペプチジルペプチダーゼ−iv阻害剤としての縮合アミノピペリジン | 
        
          | WO2007024993A2
              (en) | 2005-08-26 | 2007-03-01 | Merck & Co., Inc. | Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | 
        
          | WO2006065826A2
              (en) | 2004-12-15 | 2006-06-22 | Merck & Co., Inc. | Process to chiral beta amino acid derivatives by asymmetric hydrogenation | 
        
          | EP1829877A4
              (en) | 2004-12-24 | 2009-10-14 | Dainippon Sumitomo Pharma Co | BICYCLIC PYRROLE DERIVATIVES | 
        
          | US7635699B2
              (en) | 2004-12-29 | 2009-12-22 | Bristol-Myers Squibb Company | Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods | 
        
          | WO2006073167A1
              (ja) | 2005-01-07 | 2006-07-13 | Ono Pharmaceutical Co., Ltd. | ピロリジン誘導体 | 
        
          | EP1841770B1
              (en) | 2005-01-19 | 2009-11-11 | Merck & Co., Inc. | Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | 
        
          | JPWO2006085685A1
              (ja) | 2005-02-09 | 2008-06-26 | 武田薬品工業株式会社 | ピラゾール化合物 | 
        
          | ZA200708144B
              (en) | 2005-02-25 | 2008-11-26 | Takeda Pharmaceutical | Pyridyl acetic acid compounds | 
        
          | DE102005012874A1
              (de) | 2005-03-19 | 2006-09-21 | Sanofi-Aventis Deutschland Gmbh | Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102005012873B4
              (de) | 2005-03-19 | 2007-05-03 | Sanofi-Aventis Deutschland Gmbh | Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | TWI357902B
              (en) | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth | 
        
          | DE102005017605B4
              (de) | 2005-04-16 | 2007-03-15 | Sanofi-Aventis Deutschland Gmbh | Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | BRPI0609676A2
              (pt) | 2005-05-13 | 2011-10-18 | Lilly Co Eli | composto de glp-1 peguilado,e, uso do mesmo | 
        
          | JP2008540656A
              (ja) | 2005-05-18 | 2008-11-20 | ワイス | Tpl2キナーゼの3−シアノキノリン阻害物質ならびにそれを製造および使用する方法 | 
        
          | CN101223170A
              (zh) | 2005-05-18 | 2008-07-16 | 惠氏公司 | Tpl2激酶的4,6-二氨基-[1,7]萘啶-3-甲腈抑制剂以及其制备和使用方法 | 
        
          | US7906649B2
              (en) | 2005-05-25 | 2011-03-15 | Merck Sharp & Dohme Corp. | Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes | 
        
          | ATE432259T1
              (de) | 2005-07-20 | 2009-06-15 | Lilly Co Eli | Pyridinderivate als dipeptedyl-peptidase-hemmer | 
        
          | WO2007013689A1
              (ja) | 2005-07-29 | 2007-02-01 | Takeda Pharmaceutical Company Limited | シクロプロパンカルボン酸化合物 | 
        
          | WO2007029086A2
              (en) | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors | 
        
          | US7582803B2
              (en) | 2005-09-14 | 2009-09-01 | Amgen Inc. | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | 
        
          | WO2007063928A1
              (ja) | 2005-11-30 | 2007-06-07 | Toray Industries, Inc. | 新規な非環状アミンカルボキシアミド誘導体及びその塩 | 
        
          | AU2006326564B2
              (en) | 2005-12-14 | 2011-06-23 | Merck Sharp & Dohme Corp. | Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes | 
        
          | CA2633803A1
              (en) | 2005-12-19 | 2007-09-07 | Trustees Of Tufts College | Soft protease inhibitors and pro-soft forms thereof | 
        
          | DE602006017259D1
              (de) | 2005-12-21 | 2010-11-11 | Hoffmann La Roche | Neues salz und polymorph des dpp-iv-hemmers | 
        
          | WO2007071738A1
              (en) | 2005-12-23 | 2007-06-28 | Novartis Ag | Condensed heterocyclic compounds useful as dpp-iv inhibitors | 
        
          | ATE519780T1
              (de) | 2005-12-28 | 2011-08-15 | Novo Nordisk As | Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen | 
        
          | US20090156465A1
              (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors | 
        
          | JP5111398B2
              (ja) | 2006-01-25 | 2013-01-09 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療又は予防のためのジペプチジルペプチダーゼiv阻害剤としてのアミノシクロヘキサン類 | 
        
          | JP5161795B2
              (ja) | 2006-02-15 | 2013-03-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療又は予防のためのジペプチジルペプチダーゼivインヒビターとしてのアミノテトラヒドロピラン | 
        
          | WO2007099385A1
              (en) | 2006-03-01 | 2007-09-07 | Glenmark Pharmaceuticals S.A. | Dipeptidyl peptidase iv inhibitor compounds and compositions | 
        
          | US20080051452A1
              (en) | 2006-03-06 | 2008-02-28 | Avestha Gengraine Technologies Pvt. Ltd. | Hexanoic acid derivatives as dipeptidyl peptidase inhibitors | 
        
          | US20070270492A1
              (en) | 2006-03-06 | 2007-11-22 | Avestha Gengraine Technologies Pvt. Ltd. | Nananoic acid derivatives as dipeptidyl peptidase inhibitors | 
        
          | JP2009530281A
              (ja) | 2006-03-14 | 2009-08-27 | アムジエン・インコーポレーテツド | 代謝障害の治療に有用である二環式カルボン酸誘導体 | 
        
          | EP1996617A2
              (en) | 2006-03-15 | 2008-12-03 | Novo Nordisk A/S | Amylin derivatives | 
        
          | WO2007112347A1
              (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors | 
        
          | TW200806669A
              (en) | 2006-03-28 | 2008-02-01 | Merck & Co Inc | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | 
        
          | CA2644963A1
              (en) | 2006-03-31 | 2007-10-11 | Novartis Ag | Organic compounds | 
        
          | AU2007232311B2
              (en) | 2006-04-03 | 2012-08-09 | Mylan Laboratories Ltd | Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them | 
        
          | CN101050194B
              (zh) | 2006-04-05 | 2013-08-21 | 上海恒瑞医药有限公司 | 双环辛烷类衍生物、其制备方法及其在医药上的用途 | 
        
          | PE20080184A1
              (es) | 2006-04-11 | 2008-03-28 | Novartis Ag | Derivados de aza-biciclo[3.2.1]octan en el tratamiento de diabetes | 
        
          | NZ571761A
              (en) | 2006-04-12 | 2010-07-30 | Probiodrug Ag | 5-phenylimidazoles | 
        
          | EP2015769A4
              (en) | 2006-04-13 | 2013-12-25 | Ipsen Pharma | PHARMACEUTICAL COMPOSITIONS OF HGLP-1, EXENDINE 4 AND THEIR ANALOGUES | 
        
          | US8288339B2
              (en) | 2006-04-20 | 2012-10-16 | Amgen Inc. | GLP-1 compounds | 
        
          | TW200815377A
              (en) | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound | 
        
          | EP1852108A1
              (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations | 
        
          | BRPI0711558A2
              (pt) | 2006-05-04 | 2011-11-08 | Boeringer Ingelheim Internat Gmbh | polimorfos | 
        
          | DE102006021874B4
              (de) | 2006-05-11 | 2008-03-27 | Sanofi-Aventis | 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE502007001453D1
              (de) | 2006-05-11 | 2009-10-15 | Sanofi Aventis | 4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | 
        
          | DE102006021872B4
              (de) | 2006-05-11 | 2008-04-17 | Sanofi-Aventis | 4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | DE102006021878A1
              (de) | 2006-05-11 | 2007-11-15 | Sanofi-Aventis | Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | 
        
          | ATE552245T1
              (de) | 2006-05-15 | 2012-04-15 | Merck Sharp & Dohme | Antidiabetische bicyclische verbindungen | 
        
          | CA2652367A1
              (en) | 2006-05-16 | 2007-11-29 | Merck & Co., Inc. | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | 
        
          | JP2009190971A
              (ja) | 2006-06-06 | 2009-08-27 | Mitsubishi Tanabe Pharma Corp | 2−シアノピロリジン誘導体 | 
        
          | WO2007148185A2
              (en) | 2006-06-21 | 2007-12-27 | Pfizer Products Inc. | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | 
        
          | CA2656003C
              (en) | 2006-06-27 | 2014-03-25 | Tsuneo Yasuma | Fused cyclic compounds | 
        
          | JP2008031064A
              (ja) | 2006-07-27 | 2008-02-14 | Astellas Pharma Inc | ジアシルピペラジン誘導体 | 
        
          | EP2057160A1
              (en) | 2006-08-08 | 2009-05-13 | Boehringer Ingelheim International GmbH | Pyrrolo [3, 2 -d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus | 
        
          | WO2008022015A2
              (en) | 2006-08-11 | 2008-02-21 | Trustees Of Tufts College | Retro-inverso incretin analogues, and methods of use thereof | 
        
          | WO2008029217A2
              (en) | 2006-08-29 | 2008-03-13 | Orchid Research Laboratories Limited | Dipeptidyl peptidase iv inhibitors | 
        
          | CL2007002499A1
              (es) | 2006-08-30 | 2008-03-14 | Phenomix Corp | Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes. | 
        
          | JP2008063256A
              (ja) | 2006-09-06 | 2008-03-21 | Astellas Pharma Inc | β‐アミノ酸誘導体 | 
        
          | AU2007293028B2
              (en) | 2006-09-07 | 2012-05-31 | Amgen Inc. | Heterocyclic GPR40 modulators | 
        
          | WO2008030618A1
              (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders | 
        
          | WO2008028662A1
              (en) | 2006-09-07 | 2008-03-13 | Santhera Pharmaceuticals (Schweiz) Ag | N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus | 
        
          | JP5791228B2
              (ja) | 2006-09-13 | 2015-10-07 | 武田薬品工業株式会社 | 2−6−(3−アミノ−ピペリジン−1−イル)−3−メチル−2,4−ジオキソ−3,4−ジヒドロ−2h−ピリミジン−1−イルメチル−4−フルオロ−ベンゾニトリルの使用 | 
        
          | DK2084182T3
              (da) | 2006-10-03 | 2013-11-04 | Cadila Healthcare Ltd | Antidiabetiske forbindelser | 
        
          | WO2008040974A1
              (en) | 2006-10-07 | 2008-04-10 | Peakdale Molecular Limited | Indoles for use as dpp-iv inhibitors | 
        
          | WO2008054674A2
              (en) | 2006-10-31 | 2008-05-08 | Merck & Co., Inc. | Antidiabetic bicyclic compounds | 
        
          | US8039484B2
              (en) | 2006-10-31 | 2011-10-18 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds | 
        
          | JP2010043001A
              (ja) | 2006-11-09 | 2010-02-25 | Sanwa Kagaku Kenkyusho Co Ltd | Glp−1誘導体とその用途 | 
        
          | US7855206B2
              (en) | 2006-11-14 | 2010-12-21 | Merck Sharp & Dohme Corp. | Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | 
        
          | US7750048B2
              (en) | 2006-11-15 | 2010-07-06 | Janssen Pharmaceutica Nv | GPR40 agonists | 
        
          | EP2086975B1
              (en) | 2006-11-20 | 2012-03-14 | Bristol-Myers Squibb Company | 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods | 
        
          | WO2008061355A1
              (en) | 2006-11-24 | 2008-05-29 | Matregen Corp. | Glp-1 depot systems, and methods of manufacture and uses thereof | 
        
          | WO2008066070A1
              (fr) | 2006-11-29 | 2008-06-05 | Uha Mikakuto Co., Ltd. | Inhibiteur de dipeptidylpeptidase-iv | 
        
          | TW200838526A
              (en) | 2006-12-01 | 2008-10-01 | Astellas Pharma Inc | Carboxylic acid derivatives | 
        
          | CN101610761A
              (zh) | 2006-12-22 | 2009-12-23 | 诺瓦提斯公司 | 作为ddp-iv抑制剂的1-氨基甲基-l-苯基-环己烷衍生物 | 
        
          | JP2008156318A
              (ja) | 2006-12-26 | 2008-07-10 | Dainippon Sumitomo Pharma Co Ltd | 1,3,4−オキサジアゾール−2−オン誘導体 | 
        
          | JP2008169195A
              (ja) | 2007-01-05 | 2008-07-24 | Hanmi Pharmaceutical Co Ltd | キャリア物質を用いたインスリン分泌ペプチド薬物結合体 | 
        
          | US20090098130A1
              (en) | 2007-01-05 | 2009-04-16 | Bradshaw Curt W | Glucagon-like protein-1 receptor (glp-1r) agonist compounds | 
        
          | KR100848491B1
              (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 | 
        
          | CN101230058A
              (zh) | 2007-01-23 | 2008-07-30 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 | 
        
          | KR20080071476A
              (ko) | 2007-01-30 | 2008-08-04 | 주식회사  엘지생명과학 | 신규한 디펩티딜 펩티데이즈 iv(dpp-iv) 저해제 | 
        
          | JP2010120851A
              (ja) | 2007-02-09 | 2010-06-03 | Kyorin Pharmaceut Co Ltd | 二量化シクロ誘導体 | 
        
          | KR20090119876A
              (ko) | 2007-02-15 | 2009-11-20 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 글루카곤/glp-1 수용체 공동-항진물질 | 
        
          | EP1961742A1
              (en) | 2007-02-22 | 2008-08-27 | Novartis AG | compounds of formula (I) as serine protease inhibitors | 
        
          | WO2008112941A1
              (en) | 2007-03-13 | 2008-09-18 | Board Of Regents The University Of Texas System | Composition and method for the treatment of diseases affected by a peptide receptor | 
        
          | EP1972349A1
              (en) | 2007-03-21 | 2008-09-24 | Biocompatibles UK Limited | GLP-1 fusion peptides conjugated to polymer(s), their production and use | 
        
          | WO2008116294A1
              (en) | 2007-03-23 | 2008-10-02 | Matregen Corp. | Exendin analogs | 
        
          | WO2008118848A1
              (en) | 2007-03-23 | 2008-10-02 | Trustees Of Tufts College | N-substituted peptidomimetic inhibitors of dipeptidylpeptidase iv | 
        
          | WO2008119005A1
              (en) | 2007-03-27 | 2008-10-02 | Trustees Of Tufts College | 3,4-dehydro-proline-containing inhibitors of dipeptidylpeptidase iv | 
        
          | EP1975176A1
              (en) | 2007-03-27 | 2008-10-01 | Biocompatibles UK Limited | Novel glp-1 fusion peptides, their production and use | 
        
          | CN101274918A
              (zh) | 2007-03-30 | 2008-10-01 | 中国科学院上海药物研究所 | 一类取代五元杂环化合物,其制备方法和医学用途 | 
        
          | US8133898B2
              (en) | 2007-03-30 | 2012-03-13 | Takeda Pharmaceutical Company Limited | Renin inhibitors | 
        
          | CA2682736C
              (en) | 2007-04-03 | 2013-07-09 | Mitsubishi Tanabe Pharma Corporation | Combined use of dipeptidyl peptidase 4 inhibitor and sweetener | 
        
          | CN101279955B
              (zh) | 2007-04-03 | 2012-11-28 | 北京摩力克科技有限公司 | 作为二肽肽激酶-iv抑制剂的n-取代硫吗啉衍生物及其医药用途 | 
        
          | JP2010524932A
              (ja) | 2007-04-16 | 2010-07-22 | アムジエン・インコーポレーテツド | 置換ビフェニルフェノキシ−、チオフェニル−及びアミノフェニルプロパン酸gpr40調節物質 | 
        
          | AU2008241692B2
              (en) | 2007-04-19 | 2011-02-10 | Dong-A Pharm. Co., Ltd. | DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity | 
        
          | PE20090696A1
              (es) | 2007-04-20 | 2009-06-20 | Bristol Myers Squibb Co | Formas cristalinas de saxagliptina y procesos para preparar las mismas | 
        
          | US7829664B2
              (en) | 2007-06-01 | 2010-11-09 | Boehringer Ingelheim International Gmbh | Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof | 
        
          | AU2008258548B2
              (en) | 2007-06-08 | 2014-07-10 | Sanofi-Aventis Deutschland Gmbh | Long-acting transient polymer conjugates of exendin | 
        
          | DK2158214T3
              (da) | 2007-06-15 | 2011-12-05 | Zealand Pharma As | Glukagonanaloger | 
        
          | WO2009003681A1
              (en) | 2007-07-02 | 2009-01-08 | Santhera Pharmaceuticals (Schweiz) Ag | Dpp-iv inhibitors | 
        
          | WO2009014676A1
              (en) | 2007-07-23 | 2009-01-29 | Merck & Co., Inc. | Novel crystalline form of a dihydrochloride salt of a dipeptidyl peptidase-iv inhibitor | 
        
          | US8653059B2
              (en) | 2007-08-21 | 2014-02-18 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | 
        
          | US20090105480A1
              (en) | 2007-08-30 | 2009-04-23 | Ulrike Bromberger | Process for the preparation of a dpp-iv inhibitor | 
        
          | JP2010538049A
              (ja) | 2007-09-05 | 2010-12-09 | ノボ・ノルデイスク・エー/エス | 切断型glp−1誘導体及びその治療的使用 | 
        
          | EP2679597A1
              (en) | 2007-09-05 | 2014-01-01 | Novo Nordisk A/S | Glucagon-like peptide-1 derivatives and their pharmaceutical use | 
        
          | US20100261637A1
              (en) | 2007-09-05 | 2010-10-14 | Novo Nordisk A/S | Peptides derivatized with a-b-c-d- and their therapeutical use | 
        
          | WO2009035540A2
              (en) | 2007-09-07 | 2009-03-19 | Ipsen Pharma S.A.S. | Analogues of exendin-4 and exendin-3 | 
        
          | EP2036923A1
              (en) | 2007-09-11 | 2009-03-18 | Novo Nordisk A/S | Improved derivates of amylin | 
        
          | WO2009038204A1
              (ja) | 2007-09-17 | 2009-03-26 | Pharma Frontier Co., Ltd. | 新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするgタンパク質共役型レセプター作動剤 | 
        
          | AU2008303975B2
              (en) | 2007-09-21 | 2013-05-16 | Sanofi | (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | 
        
          | NZ584049A
              (en) | 2007-09-21 | 2011-05-27 | Sanofi Aventis | (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | 
        
          | US8338450B2
              (en) | 2007-09-21 | 2012-12-25 | Lupin Limited | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors | 
        
          | CN102083783A
              (zh) | 2007-10-10 | 2011-06-01 | 安姆根有限公司 | 取代的联苯gpr40调节剂 | 
        
          | CN101417999A
              (zh) | 2007-10-25 | 2009-04-29 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 | 
        
          | MX2010004435A
              (es) | 2007-10-26 | 2010-05-13 | Japan Tobacco Inc | Compuestos espiro y uso farmaceutico de los mismos. | 
        
          | AU2008319418B2
              (en) | 2007-10-29 | 2013-08-15 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds | 
        
          | EP2214691B1
              (en) | 2007-10-30 | 2015-09-30 | Indiana University Research and Technology Corporation | Compounds exhibiting glucagon antagonist and glp-1 agonist activity | 
        
          | WO2009070314A2
              (en) | 2007-11-26 | 2009-06-04 | Teva Pharmaceutical Industries Ltd. | Crystalline form of sitagliptin | 
        
          | RU2489439C2
              (ru) | 2007-11-30 | 2013-08-10 | Новартис Аг | Органические соединения | 
        
          | CA2707448C
              (en) | 2007-12-11 | 2014-10-14 | Cadila Healthcare Limited | Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities | 
        
          | WO2009080024A1
              (en) | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising an incretin mimetic | 
        
          | WO2009080032A1
              (en) | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising a systemically active small peptide | 
        
          | CA2710109C
              (en) | 2007-12-21 | 2016-07-19 | Lg Life Sciences Ltd. | Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent | 
        
          | CN101468988A
              (zh) | 2007-12-26 | 2009-07-01 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 | 
        
          | TW200938200A
              (en) | 2007-12-28 | 2009-09-16 | Dainippon Sumitomo Pharma Co | Methyl-substituted piperidine derivative | 
        
          | JP2011509289A
              (ja) | 2008-01-10 | 2011-03-24 | サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド | 新規なアシルシアノピロリジン誘導体 | 
        
          | AU2009207297B2
              (en) | 2008-01-24 | 2011-11-10 | Panacea Biotec Limited | Novel heterocyclic compounds | 
        
          | US20090238879A1
              (en) | 2008-01-24 | 2009-09-24 | Northwestern University | Delivery scaffolds and related methods of use | 
        
          | WO2009099172A1
              (ja) | 2008-02-07 | 2009-08-13 | Takeda Pharmaceutical Company Limited | 医薬 | 
        
          | WO2009099171A1
              (ja) | 2008-02-07 | 2009-08-13 | Takeda Pharmaceutical Company Limited | 医薬 | 
        
          | KR100864584B1
              (ko) | 2008-02-25 | 2008-10-24 | 성균관대학교산학협력단 | 비오틴으로 수식된 엑센딘 유도체, 이의 제조방법 및 이의용도 | 
        
          | CA2717518C
              (en) | 2008-03-05 | 2017-03-21 | National Health Research Institutes | Pyrrolidine derivatives | 
        
          | EP2260017A1
              (en) | 2008-03-06 | 2010-12-15 | Amgen, Inc | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders | 
        
          | CN101959405B
              (zh) | 2008-03-07 | 2014-07-02 | 转化技术制药有限责任公司 | 治疗糖尿病的氧杂二氮杂蒽化合物 | 
        
          | RU2010141562A
              (ru) | 2008-03-10 | 2012-04-20 | Дайниппон Сумитомо Фарма Ко., Лтд. (Jp) | Бициклическое пиррольное соединение | 
        
          | US20090247532A1
              (en) | 2008-03-28 | 2009-10-01 | Mae De Ltd. | Crystalline polymorph of sitagliptin phosphate and its preparation | 
        
          | CN101565408A
              (zh) | 2008-04-25 | 2009-10-28 | 国家新药筛选中心 | 一类受体信号转导增效剂,其制备方法和用途 | 
        
          | WO2009149148A2
              (en) | 2008-06-03 | 2009-12-10 | Trustees Of Tufts College | Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction | 
        
          | JP5604297B2
              (ja) | 2008-06-17 | 2014-10-08 | 株式会社糖鎖工学研究所 | 糖鎖付加glp−1ペプチド | 
        
          | CL2009001424A1
              (es) | 2008-06-17 | 2010-04-30 | Univ Indiana Res & Tech Corp | Peptido tipo glucagon; dimero que comprende dos de dichos peptidos; composicion farmaceutica que lo comprende; y su uso para tratar diabetes o inducir perdida de peso. | 
        
          | WO2009155257A1
              (en) | 2008-06-17 | 2009-12-23 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers | 
        
          | ES2527768T5
              (es) | 2008-07-03 | 2018-02-08 | Ratiopharm Gmbh | Sales cristalinas de sitagliptina | 
        
          | WO2010012650A1
              (en) | 2008-07-28 | 2010-02-04 | Syddansk Universitet | Compounds for the treatment of metabolic diseases | 
        
          | UY32030A
              (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" | 
        
          | US8530413B2
              (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments | 
        
          | TW201221505A
              (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament | 
        
          | TW201215388A
              (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |